Evidence map›Paper›PMID 28848618›Full record

ArticleOxidative medicine and cellular longevity2017

Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer.

Juan Carlos Cantón-Romero, Alejandra Guillermina Miranda-Díaz, Jose Luis Bañuelos-Ramírez, Sandra Carrillo-Ibarra, Sonia Sifuentes-Franco, José Alberto Castellanos-González, Adolfo Daniel Rodríguez-Carrizalez

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Effect ofAntioxidants (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Juan Carlos Cantón-RomeroHospital of Gynecology and Obstetrics, Department of Oncology Gynecology, Sub-Specialty Medical Unit, National Occidental Medical Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.
Alejandra Guillermina Miranda-DíazInstitute of Experimental and Clinical Therapeutics, Department of Physiology, University Health Sciences Centre, University of Guadalajara, Guadalajara, JAL, Mexico.ORCID 0000-0002-3635-6135
Jose Luis Bañuelos-RamírezHospital of Gynecology and Obstetrics, Department of Oncology Gynecology, Sub-Specialty Medical Unit, National Occidental Medical Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.
Sandra Carrillo-IbarraInstitute of Experimental and Clinical Therapeutics, Department of Physiology, University Health Sciences Centre, University of Guadalajara, Guadalajara, JAL, Mexico.ORCID 0000-0001-8837-5533
Sonia Sifuentes-FrancoInstitute of Experimental and Clinical Therapeutics, Department of Physiology, University Health Sciences Centre, University of Guadalajara, Guadalajara, JAL, Mexico.
José Alberto Castellanos-GonzálezSpecialties Hospital, National Occidental Medical Centre, Mexican Social Security Institute, Guadalajara, JAL, Mexico.
Adolfo Daniel Rodríguez-CarrizalezInstitute of Experimental and Clinical Therapeutics, Department of Physiology, University Health Sciences Centre, University of Guadalajara, Guadalajara, JAL, Mexico.ORCID 0000-0001-9093-9406
Universidad de Guadalajara · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diverse proinflammatory biomarkers and oxidative stress are strongly associated with advanced epithelial ovarian cancer (EOC).

Indexed as

AdultAgedAntioxidantsAscitesBiomarkers, TumorCarcinoma, Ovarian EpithelialDrug Resistance, NeoplasmFemaleHumansInflammationInterleukin-6IsoprostanesLipid PeroxidesMiddle AgedNeoplasms, Glandular and EpithelialOvarian NeoplasmsAntioxidantsBiomarkers, TumorInterleukin-6IsoprostanesLipid PeroxidesPlatinumTumor Necrosis Factor-alpha

Identifiers

PMID28848618
PMCPMC5564108
OpenAlexW2743499784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.